Dilara Ayyildiz

Dilara Ayyildiz

Auto-generated profile, based on publicly available information

Dilara Ayyildiz

Netherlands Institute for Neuroscience, Amsterdam Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
Giulia AntonialiGiulia Antoniali
Giulia Antoniali
Emiliano DallaEmiliano Dalla
Emiliano Dalla
GMGiovanna Mangiapane
Giovanna Mangiapane
XZXiaolong Zhao
Xiaolong Zhao
XJXinming Jing
Xinming Jing
Gianluca TellGianluca Tell
Gianluca Tell
Increasing evidence suggests different, not completely understood roles of microRNA biogenesis in the development and progression of lung cancer. The overexpression of the DNA repair protein apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is an important cause of poor chemotherapeutic response in lung cancer and its involvement in onco-miRNAs biogenesis has been recently described. Whether APE1 regulates miRNAs acting as prognostic biomarkers of lung cancer has not been investigated, yet. In this study, we analyzed miRNAs differential expression upon APE1 depletion in the A549 lung cancer cell line using high-throughput methods. We defined a signature of 13 miRNAs that strongly correlate with APE1 expression in human lung cancer: miR-1246, miR-4488, miR-24, miR-183, miR-660, miR-130b, miR-543, miR-200c, miR-376c, miR-218, miR-146a, miR-92b and miR-33a. Functional enrichment analysis of this signature revealed its biological relevance in cancer cell proliferation and survival. We validated DICER1 as a direct functional target of the APE1-regulated miRNA-33a-5p and miR-130b-3p. Importantly, IHC analyses of different human tumors confirmed a negative correlation existing between APE1 and Dicer1 protein levels. DICER1 downregulation represents a prognostic marker of cancer development but the mechanisms at the basis of this phenomenon are still completely unknown. Our findings, suggesting that APE1 modulates DICER1 expression via miR-33a and miR-130b, reveal new mechanistic insights on DICER1 regulation, which are of relevance in lung cancer chemoresistance and cancer invasiveness.

13 October 2023 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
DADilara Ayyildiz
Dilara Ayyildiz
GBGuendalina Bergonzoni
Guendalina Bergonzoni
AMAlan Monziani
Alan Monziani
TTTakshashila Tripathi
Takshashila Tripathi
JDJessica Döring
Jessica Döring
MBMarta Biagioli
Marta Biagioli
Alternative splicing (AS) appears to be altered in Huntington’s disease (HD), but its significance for early, pre-symptomatic disease stages has not been inspected. Here, taking advantage of Htt CAG knock-in mouse in vitro and in vivo models, we demonstrate a correlation between Htt CAG repeat length and increased aberrant linear AS, specifically affecting neural progenitors and, in vivo, the striatum prior to overt behavioral phenotypes stages. Remarkably, a significant proportion (36%) of the aberrantly spliced isoforms are not-functional and meant to non-sense mediated decay (NMD). The expanded Htt CAG repeats further reflect on a previously neglected, global impairment of back-splicing, leading to decreased circular RNAs production in neural progenitors. Integrative transcriptomic analyses unveil a network of transcriptionally altered micro-RNAs and RNA-binding proteins (Celf, hnRNPs, Ptbp, Srsf, Upf1, Ythd2) which might influence the AS machinery, primarily in neural cells. We suggest that this unbalanced expression of linear and circular RNAs might alter neural fitness, contributing to HD pathogenesis.

15 November 2022 in The FEBS Journal
Verified
Journal Article
Closed access
MCMarta Codrich
Marta Codrich
MDMonica Degrassi
Monica Degrassi
MMMATILDE CLARISSA MALFATTI
MATILDE CLARISSA MALFATTI
Giulia AntonialiGiulia Antoniali
Giulia Antoniali
AGAndrea Gorassini
Andrea Gorassini
Gianluca TellGianluca Tell
Gianluca Tell

1 August 2021 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
GGGizem Gulfidan
Gizem Gulfidan
HBHande Beklen
Hande Beklen
ISIndu Sinha
Indu Sinha
FKFulya Kucukalp
Fulya Kucukalp
BCBuse Caloglu
Buse Caloglu
Raghu SinhaRaghu Sinha
Raghu Sinha
Esophageal squamous cell carcinoma (ESCC) is among the most dangerous cancers with high mortality and lack of robust diagnostics and personalized/precision therapeutics. To achieve a systems-level understanding of tumorigenesis, unraveling of variations in the protein interactome and determination of key proteins exhibiting significant alterations in their interaction patterns during tumorigenesis are crucial. To this end, we have described differential protein-protein interactions and differentially interacting proteins (DIPs) in ESCC by utilizing the human protein interactome and transcriptome. Furthermore, DIP-centered modules were analyzed according to their potential in elucidation of disease mechanisms and improvement of efficient diagnostic, prognostic, and treatment strategies. Seven modules were presented as potential diagnostic, and 16 modules were presented as potential prognostic biomarker candidates. Importantly, our findings also suggest that 30 out of the 53 repurposed drugs were noncancer drugs, which could be used in the treatment of ESCC. Interestingly, 25 of these, proposed as novel drug candidates here, have not been previously associated in a context of esophageal cancer. In this context, risperidone and clozapine were validated for their growth inhibitory potential in three ESCC lines. Our findings offer a high potential for the development of innovative diagnostic, prognostic, and therapeutic strategies for further experimental studies in line with predictive diagnostics, targeted prevention, and personalization of medical services in ESCC specifically, and personalized cancer care broadly.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
GTGiorgia Tosoni
Giorgia Tosoni
APAmber Penning
Amber Penning
DADilara Ayyildiz
Dilara Ayyildiz
SSSarah Snoeck
Sarah Snoeck
SPSuresh Kumar Poovathingal
Suresh Kumar Poovathingal
ESEvgenia Salta
Evgenia Salta
Background: Alzheimer’s disease (AD) is a progressive, irreversible disorder accounting for 50‐70% of all dementia cases. Given the current lack of disease‐modifying therapies, systematic profiling of the cell type‐ and cell state‐specific molecular signatures of resilience and vulnerability to AD may reveal novel therapeutic avenues. Adult hippocampal neurogenesis (AHN) refers to the birth of new neurons in the neurogenic ‘niche’ of a hippocampal subregion, the dentate gyrus (DG). AHN drops sharply in AD, and positively correlates with ante‐mortem cognition. Our work and previous reports show that boosting AHN in AD mice restores AHN‐related memory. Hence, harnessing AHN in human AD brain may provide novel strategies to prevent or counteract dementia. Insights into the molecular and cellular regulatory networks maintaining homeostasis of the human neurogenic microenvironment are currently missing.Method: Here, we employ single‐nucleus RNA sequencing technology in the human AHN niche to profile cell type specific molecular signatures of AHN and their changes during the course of AD pathology and in resilient brains.Result: We developed a novel protocol for precise microdissection of the AHN niche in tissue sections of postmortem human brain, which yields high‐quality input material, enriched for niche‐resident cell populations. We employ in silico ‘dissection’ of cellular populations putatively including neurogenic cell types, and lineage trajectories to identify any (rare) bona fide progenitors.Conclusion: Using previously published and our own datasets, we identify species‐conserved and human‐specific markers that could be used for more reliable identification of adult neurogenic populations and of their transcriptional alterations in AD and resilient brains.